BioNTech SE (BNTX) Work In Process (2018 - 2021)

BioNTech SE has disclosed Work In Process across 4 years of filings, most recently posting $96.7 million for Q4 2021.

• Work In Process for Q4 2021 came in at $96.7 million, up 317.92% year-over-year; the trailing twelve-month figure through Dec 2021 was $96.7 million (up 317.92% YoY), and the FY2021 annual result was $96.7 million, up 317.92% from the prior year.
• Work In Process came in at $96.7 million for Q4 2021 at BioNTech SE, up from $23.1 million in the prior quarter.
• In the past five years, Work In Process ranged from a high of $96.7 million in Q4 2021 to a low of $91311.7 in Q4 2018.
• The 4-year median for Work In Process is $13.2 million (2019), against an average of $30.8 million.
• Across the five-year window, Work In Process surged 3400.86% in 2019 and jumped 317.92% in 2021, its largest moves.
• BioNTech SE's Work In Process stood at $91311.7 in 2018, then soared by 3400.86% to $3.2 million in 2019, then jumped by 623.57% to $23.1 million in 2020, then surged by 317.92% to $96.7 million in 2021.
• The last three Work In Process figures came in at $96.7 million (Q4 2021), $23.1 million (Q4 2020), and $3.2 million (Q4 2019), per Business Quant data.